-
Lorcaserin submitted for FDA review, FDA advisory panel votes against phentermine/topiramate, mixed vote on rosiglitazone, advisory panel votes to remove breast cancer indication from bevacizumab labeling, no increase in seizures found with DTaP vaccine, new REMS for quinine.
-
A great debate continues regarding appropriate management of hypertension during acute stroke. In the U.S., permissive hypertension is popular with recommendations that antihypertensive medications be discontinued when an acute ischemic stroke occurs.
-
-
Concern about serotonin syndrome should not prevent migraineurs who have mood disorders from being treated judiciously with the combination of triptans and serotonergic medications.
-
Confocal microscopy of the cornea may be a useful diagnostic test to identify patients with small-fiber neuropathies.
-
Obstructive sleep apnea causes a variety of alterations in the control of cerebral blood flow, contributing to the risk for stroke.
-
In a cohort of patients presenting with acute myelitis, motor onset and a subsequent relapse were the strongest predictors of residual disability. An abnormal baseline brain MRI was the strongest predictor for conversion to multiple sclerosis.
-
Ten risk factors are associated with approximately 90% of ischemic and hemorrhagic strokes. Hypertension, smoking, abdominal obesity, physical inactivity, and diet are the most important modifiable risk factors for stroke.
-
-
WHO recommendations for antiviral use for H1N1 flu; antibiotic use trends for acute respiratory tract infection; denosumab clears FDA Expert Panel; FDA Actions.